Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

NCT04530552 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

NIH

Sponsor class

Conditions

Localized Prostate Carcinoma
Prostate Adenocarcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8

Interventions

DRUG: Apalutamide
PROCEDURE: Biospecimen Collection
OTHER: Quality-of-Life Assessment

Sponsor

National Cancer Institute (NCI)